Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441480
Status:
COMPLETED
Last Update Posted:
2012-01-13
First Post:
2007-02-28
Brief Title:
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels
Sponsor:
Enzymotec
Organization:
Enzymotec
Study Overview
Official Title:
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels in Healthy Hyperlipidemic Subjects
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether plant sterols esterified to fish oil fatty acids in a fish oil matrix improve the lipid profile predominantly LDL-cholesterol and TG concentrations in healthy hyperlipidemic subjects
Detailed Description:
Phytosterols and omega-3 fatty acids n-3 are natural food ingredients with potential cardiovascular CVD benefits Phytosterols inhibit dietary cholesterol absorption and biliary cholesterol re-absorption thereby reducing blood cholesterol levels while consumption of n-3 is associated with a significant reduction in plasma triglyceride concentrations Furthermore n-3 may also beneficially modify a number of other risk factors of CHD like anti-inflammatory and anti-thrombotic
The primary objective of this study is to determine whether plant sterols esterified to fish oil fatty acids in a fish oil matrix improve the lipid profile predominantly LDL-cholesterol and TG concentrations in healthy hyperlipidemic subjects In addition the supplement efficacy to lower other CVD-related risk factors of healthy will be evaluated
The primary objective of this study is to determine whether plant sterols esterified to fish oil fatty acids in a fish oil matrix improve the lipid profile predominantly LDL-cholesterol and TG concentrations in healthy hyperlipidemic subjects In addition the supplement efficacy to lower other CVD-related risk factors of healthy will be evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None